Epoch 40: Biotech VC Performance as a Proxy for Market Health

Using Venture Capital Metrics to Measure Sentiment

Hello Avatar!  Welcome to another week of biotech analysis. Today’s commentary is as always on Thursday focused on the general market update.  For the week XBI was DOWN -1.5% and remains green at +8% for the year.  For those of you new here, the purpose of the Thursday updates is to dive deep into the metrics that provide a window into the health of bot…